These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7427657)

  • 1. Systemic lupus erythematosus induced by aminoglutethimide.
    McCraken M; Benson EA; Hickling P
    Br Med J; 1980 Nov; 281(6250):1254. PubMed ID: 7427657
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual pharmacological effect of aminoglutethamide.
    Hickling P
    Lupus; 1994 Oct; 3(5):435. PubMed ID: 7842001
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of aminoglutethemide on the activity of a case of a connective tissue disorder with features of systemic lupus erythematosus.
    Etherington J; Haynes P; Buchanan N
    Lupus; 1993 Dec; 2(6):387. PubMed ID: 8136824
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancytopenia induced by aminoglutethimide in the treatment of breast cancer.
    Lawrence B; Santen RJ; Lipton A; Harvey HA; Hamilton R; Mercurio T
    Cancer Treat Rep; 1978 Oct; 62(10):1581-3. PubMed ID: 213192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
    Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
    Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglutethimide in the management of advanced breast cancer.
    Smith IE; Coombes RC; Ford HT; Gazet JC; Harmer C; Jones M; McKinna JA; Powles TJ
    Eur J Cancer (1965); 1980; Suppl 1():99-101. PubMed ID: 7318876
    [No Abstract]   [Full Text] [Related]  

  • 7. Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.
    Harris AL; Hughes G; Barrett AJ; Abusrewil S; Dowsett M; Smith IE
    Br J Cancer; 1986 Jul; 54(1):119-22. PubMed ID: 3730249
    [No Abstract]   [Full Text] [Related]  

  • 8. Agranulocytosis induced by aminoglutethimide.
    Mathijs R; Coolen D; Hermans-Debaive C
    Acta Clin Belg; 1988; 43(2):146-8. PubMed ID: 2840788
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical adrenalectomy with aminoglutethimide-cortisol in the treatment of metastatic breast carcinoma.
    Paridaens R; Van Haelen C; Heuson JC
    Eur J Cancer (1965); 1980; Suppl 1():103-6. PubMed ID: 7318860
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
    Brufman G; Biran S
    Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advanced breast cancer treated with aminoglutethimide].
    Huang HY; Fei LM; Liu WH
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):178-81. PubMed ID: 3094873
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of metastasizing breast cancer with aminoglutethimide].
    Kübböck J; Ludwig H; Aiginger P; Linkesch W; Pötzi P
    Acta Med Austriaca; 1982; 9(5-6):221-6. PubMed ID: 7164757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of aminoglutethimide (orimeten) in disseminated breast cancer].
    Nadezhdina TM; Vyshinskaia GV; Lichinitser MR; Bassalyk LS; Garin AM
    Vopr Onkol; 1987; 33(5):79-82. PubMed ID: 3590672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aminoglutethimide in the treatment of metastasizing breast carcinoma in old age].
    Gorgone S; Lorenzini C; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
    Chir Ital; 1987 Apr; 39(2):166-75. PubMed ID: 3652316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukopenia associated with aminoglutethimide therapy: a case report.
    Austerlitz J
    Cancer Treat Rep; 1982 Oct; 66(10):1879. PubMed ID: 7127328
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
    Brufman G; Biran S
    Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of metastatic breast cancer with aminoglutethimide after failure of tamoxifen].
    Brufman G; Biran S
    Harefuah; 1984 Dec; 107(12):377-99. PubMed ID: 6532917
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience with 6-aminoglutethimide in the treatment of metastatic breast cancer.
    Koelmeyer TD; Stephens EJ; Wood HF
    Clin Oncol; 1978 Dec; 4(4):323-7. PubMed ID: 729221
    [No Abstract]   [Full Text] [Related]  

  • 19. Manipulating the hormones.
    Markham G
    Nurs Mirror; 1984 Oct; 159(13):40-1. PubMed ID: 6387637
    [No Abstract]   [Full Text] [Related]  

  • 20. Aminoglutethimide.
    Med Lett Drugs Ther; 1981 Aug; 23(16):71-2. PubMed ID: 7254130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.